查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945343

2026年全球免疫診斷市場報告

Immunodiagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，免疫診斷市場發展迅速，預計將從2025年的243.2億美元成長到2026年的261.6億美元，複合年成長率達7.5%。過去幾年的成長可歸因於感染疾病和慢性病的增加、臨床實驗室網路的擴張、對疾病早期檢測需求的不斷成長、基於抗體的診斷方法的廣泛應用以及標準化免疫檢測技術的普及。

預計未來幾年免疫診斷市場將維持強勁成長，2030年市場規模將達到357.6億美元，複合年成長率（CAGR）為8.1%。預測期內的成長要素包括：個人化診斷的日益普及、自動化檢查室投資的增加、照護現場免疫診斷的擴展、人工智慧賦能的結果解讀的日益整合，以及對預防性檢測的日益重視。預測期內的主要趨勢包括：自動化免疫檢測設備的普及率不斷提高、對高靈敏度診斷測試的需求不斷成長、快速免疫診斷試劑盒的使用日益廣泛、多重檢測能力的提升以及實驗室數據管理系統的日益整合。

預計未來幾年，慢性病和感染疾病的增加將推動免疫診斷市場的成長。盛行率上升指的是患有長期或復發性疾病（例如癌症、自體免疫疾病、心血管疾病和慢性病毒感染疾病）的人數不斷增加，這些疾病需要基於抗原-抗體反應進行重複診斷檢測，以進行疾病檢測和監測。人口老化和預期壽命延長導致多種合併症發病率上升，以及患有這些疾病的終生風險增加，進一步強化了這一趨勢。免疫診斷市場在應對日益嚴重的疾病負擔方面發揮關鍵作用，它能夠早期識別疾病特異性生物標記，輔助治療方法的選擇，並在醫院、診斷檢查室和照護現場監測治療效果。例如，根據總部位於瑞士的世界衛生組織（世衛組織）的數據，截至2025年6月，歐洲地區每年有180萬人死於可預防的慢性非傳染性疾病。

免疫診斷市場的主要企業正致力於開發創新解決方案，例如自動化化學冷光免疫檢測（CLIA），以提高診斷準確性、縮短檢測時間並提升檢查室效率。同時，他們也在開發標靶檢測方法，例如肺炎鏈球菌抗原免疫診斷檢測，以輔助診斷肺炎球菌性肺炎。肺炎鏈球菌抗原免疫診斷檢測旨在檢測體液中的肺炎球菌抗原，從而實現肺炎鏈球菌感染的早期發現。自動化化學冷光免疫檢測結合了發光化學和自動化技術，能夠快速且準確地檢測血液和其他檢體中的特定蛋白質和抗體。例如，2025年9月，總部位於義大利的診斷公司DiaSorin SpA推出了用於評估自體免疫甲狀腺疾病的LIAISON® TSH-R Ab檢測。此檢測方法採用雙橋結構以提高抗體特異性，與現有的 LIAISON® 分析儀無縫整合以最佳化工作流程，並獲得 CE 標誌認證，可在受監管的市場中使用。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球免疫診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 自動化免疫檢測設備的應用日益普及
    • 對高靈敏度診斷測試的需求日益成長
    • 擴大快速免疫診斷試劑盒的使用範圍
    • 擴展的多重測試能力
    • 加強檢查室數據管理系統的整合

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 診斷檢查室
  • 學術研究機構
  • CRO（受託研究機構）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球免疫診斷市場：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 全球免疫診斷市場規模、對比及成長率分析
  • 全球免疫診斷市場表現：規模與成長，2020-2025年
  • 全球免疫診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 試劑、耗材和設備
  • 透過技術
  • 酵素免疫分析法、化學冷光免疫檢測、螢光免疫分析、快速檢測及其他技術
  • 透過使用
  • 感染疾病、腫瘤學和內分泌學、骨骼和礦物質疾病、自體免疫疾病、心臟生物標記、藥物監測及其他應用
  • 最終用戶
  • 醫院、診所和診斷檢查室
  • 按類型細分：試劑和耗材
  • 抗體、檢測試劑盒、緩衝液和基材
  • 按類型細分：設備
  • 免疫檢測分析儀，ELISA 閱讀器

第10章 區域與國家分析

  • 全球免疫診斷市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球免疫診斷市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 免疫診斷市場：競爭格局及市場佔有率（2024年）
  • 免疫診斷市場：公司估值矩陣
  • 免疫診斷市場：公司概況
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.

第37章：其他領先和創新企業

  • Bio-Rad Laboratories Inc., DiaSorin SpA, bioMerieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols SA, Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年免疫診斷市場：提供新機會的國家
  • 2030年免疫診斷市場：充滿新機會的細分市場
  • 2030年免疫診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MIMMU03_G26Q1

Immunodiagnostics is a diagnostic approach that relies primarily on the antigen-antibody response for detecting serum insulin. These tests are employed to identify antibodies and parasite antigens.

The principal products in the field of immunodiagnostics include reagents and consumables, instruments and software, and services. Reagents are substances used to initiate chemical reactions with other substances to detect the presence of specific substances, while consumables refer to traceable items utilized in the execution of analysis techniques. The technologies involved encompass enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid tests, and others. These technologies find applications in various medical fields such as infectious diseases, oncology, endocrinology, bone and mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and more. The end-users of immunodiagnostics include hospitals, clinics, diagnostic laboratories, academic and research institutes, among others.

Tariffs are influencing the immunodiagnostics market by increasing costs of imported reagents, antibodies, assay kits, diagnostic instruments, and electronic components used in immunoassay analyzers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to dependence on imported consumables and instruments, while Asia-Pacific faces pricing pressure on manufacturing and exports. These tariffs are raising test costs and impacting procurement budgets. However, they are also driving localization of reagent production, regional manufacturing of diagnostic instruments, and innovation in cost-efficient immunodiagnostic solutions.

The immunodiagnostics market research report is one of a series of new reports from The Business Research Company that provides immunodiagnostics market statistics, including immunodiagnostics industry global market size, regional shares, competitors with a immunodiagnostics market share, detailed immunodiagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the immunodiagnostics industry. This immunodiagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunodiagnostics market size has grown strongly in recent years. It will grow from $24.32 billion in 2025 to $26.16 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of infectious and chronic diseases, expansion of clinical laboratory networks, growing demand for early disease detection, rising use of antibody-based diagnostics, availability of standardized immunoassay technologies.

The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $35.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of personalized diagnostics, rising investments in automated laboratories, expansion of point-of-care immunodiagnostics, growing integration of AI-based result interpretation, increasing focus on preventive healthcare testing. Major trends in the forecast period include increasing adoption of automated immunoassay analyzers, rising demand for high-sensitivity diagnostic tests, growing use of rapid immunodiagnostic kits, expansion of multiplex testing capabilities, enhanced integration of laboratory data management systems.

The increasing prevalence of chronic and infectious diseases is expected to drive the growth of the immunodiagnostics market in the coming years. Rising prevalence refers to the growing number of individuals living with long-term or recurring conditions such as cancer, autoimmune disorders, cardiovascular diseases, and chronic viral infections that require repeated diagnostic testing based on antigen-antibody interactions for disease detection and monitoring. This trend continues to intensify as populations age and life expectancy increases, leading to a higher incidence of multiple comorbidities and a greater lifetime risk of developing such conditions. The immunodiagnostics market plays a critical role in addressing this expanding disease burden by enabling early identification of disease-specific biomarkers, supporting treatment selection, and monitoring therapeutic response across hospitals, diagnostic laboratories, and point-of-care settings. For instance, in June 2025, according to the World Health Organization (WHO), a Switzerland-based organization, 1.8 million avoidable deaths occur each year in the European region due to chronic noncommunicable diseases.

Major companies operating in the immunodiagnostics market are increasingly emphasizing the development of innovative solutions such as automated chemiluminescence immunoassays (CLIAs) to improve diagnostic accuracy, shorten testing time, and enhance laboratory efficiency. In parallel, companies are also advancing targeted assays such as the S. pneumoniae antigen immunodiagnostic assay to support the diagnosis of pneumococcal pneumonia. The S. pneumoniae antigen immunodiagnostic assay is designed to detect Streptococcus pneumoniae antigens in bodily fluids, enabling timely identification of pneumococcal infections. Automated chemiluminescence immunoassays use light-emitting chemical reactions combined with automation to rapidly and precisely detect specific proteins or antibodies in blood or other samples. For instance, in September 2025, DiaSorin S.p.A., an Italy-based diagnostics company, launched the LIAISON(R) TSH-R Ab assay for the assessment of autoimmune thyroid disorders. The assay offers improved antibody specificity through a double-bridge architecture, integrates seamlessly with existing LIAISON(R) analyzers to optimize workflows, and features CE-marked compatibility for use across regulated markets.

In May 2023, Freenome, a biotechnology company based in the U.S., acquired Oncimmune for an undisclosed amount. This acquisition is intended to enhance Freenome's capabilities in early cancer detection by incorporating Oncimmune's innovative technology and expertise in immune profiling. The move aims to strengthen Freenome's position in the oncology diagnostics market and expand its portfolio of liquid biopsy solutions. Oncimmune, located in the UK, specializes in developing technologies for immune profiling and biomarker discovery to aid in cancer diagnosis and monitoring.

Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMerieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)

North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunodiagnostics market consists of revenues earned by entities by providing agglutination, nephelometry, immunoprecipitation, and radial immunodiffusion test services. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunodiagnostics market also includes sales of anti-streptolysin-O latex, infectious mononucleosis slide, rheumatoid factor, and syphilis serology reagent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunodiagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunodiagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Consumables; Instruments
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Drug Monitoring; Other Applications
  • 4) By End User: Hospitals; Clinics; Diagnostic Laboratories
  • Subsegments:
  • 1) By Reagents And Consumables: Antibodies; Assay Kits; Buffers And Substrates
  • 2) By Instruments: Immunoassay Analyzers; ELISA Readers
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Danaher Corporation; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; bioMerieux SA; Sysmex Corporation; Becton Dickinson and Company; Grifols S.A.; Ortho Clinical Diagnostics; Beckman Coulter Inc.; Fujirebio Holdings Inc.; Quidel Corporation; Luminex Corporation; Bio-Techne Corporation; PerkinElmer Inc.; Merck KGaA; Gold Standard Diagnostics Corp.; OraSure Technologies Inc.; Immunodiagnostic Systems Holdings Plc (IDS)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunodiagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunodiagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunodiagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunodiagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Automated Immunoassay Analyzers
    • 4.2.2 Rising Demand For High-Sensitivity Diagnostic Tests
    • 4.2.3 Growing Use Of Rapid Immunodiagnostic Kits
    • 4.2.4 Expansion Of Multiplex Testing Capabilities
    • 4.2.5 Enhanced Integration Of Laboratory Data Management Systems

5. Immunodiagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Diagnostic Laboratories
  • 5.4 Academic Research Institutes
  • 5.5 Contract Research Organizations

6. Immunodiagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunodiagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunodiagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunodiagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunodiagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunodiagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunodiagnostics Market Segmentation

  • 9.1. Global Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Consumables, Instruments
  • 9.2. Global Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies
  • 9.3. Global Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
  • 9.4. Global Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Diagnostic Laboratories
  • 9.5. Global Immunodiagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Assay Kits, Buffers And Substrates
  • 9.6. Global Immunodiagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassay Analyzers, ELISA Readers

10. Immunodiagnostics Market Regional And Country Analysis

  • 10.1. Global Immunodiagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunodiagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunodiagnostics Market

  • 11.1. Asia-Pacific Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunodiagnostics Market

  • 12.1. China Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunodiagnostics Market

  • 13.1. India Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunodiagnostics Market

  • 14.1. Japan Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunodiagnostics Market

  • 15.1. Australia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunodiagnostics Market

  • 16.1. Indonesia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunodiagnostics Market

  • 17.1. South Korea Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunodiagnostics Market

  • 18.1. Taiwan Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunodiagnostics Market

  • 19.1. South East Asia Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunodiagnostics Market

  • 20.1. Western Europe Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunodiagnostics Market

  • 21.1. UK Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunodiagnostics Market

  • 22.1. Germany Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunodiagnostics Market

  • 23.1. France Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunodiagnostics Market

  • 24.1. Italy Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunodiagnostics Market

  • 25.1. Spain Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunodiagnostics Market

  • 26.1. Eastern Europe Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunodiagnostics Market

  • 27.1. Russia Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunodiagnostics Market

  • 28.1. North America Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunodiagnostics Market

  • 29.1. USA Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunodiagnostics Market

  • 30.1. Canada Immunodiagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunodiagnostics Market

  • 31.1. South America Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunodiagnostics Market

  • 32.1. Brazil Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunodiagnostics Market

  • 33.1. Middle East Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunodiagnostics Market

  • 34.1. Africa Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunodiagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunodiagnostics Market Regulatory and Investment Landscape

36. Immunodiagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Immunodiagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunodiagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunodiagnostics Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Immunodiagnostics Market Other Major And Innovative Companies

  • Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMerieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp.

38. Global Immunodiagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunodiagnostics Market

40. Immunodiagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Immunodiagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunodiagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunodiagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer